Vergoeding 2020-2024 voor ATC-subgroep L01BC : Pyrimidinederivaten
- Raming voor de totale Zvw-populatie
| 2020 | 2021 | 2022 | 2023* | 2024* | |
|---|---|---|---|---|---|
| L01BC01 Cytarabine | 287.766 | 305.601 | 267.280 | 287.343 | 249.365 |
| L01BC05 Gemcitabine | 573.159 | 503.419 | 477.209 | 623.906 | 574.747 |
| L01BC06 Capecitabine | 1.521.547 | 1.700.598 | 1.352.903 | 1.467.099 | 1.329.282 |
| L01BC07 Azacitidine | 14.511.095 | 7.935.589 | 3.386.140 | 2.483.409 | 1.806.799 |
| L01BC08 Decitabine | 4.283.382 | 3.613.136 | 3.647.623 | 2.715.330 | 1.791.065 |
| L01BC53 Tegafur combinatiepreparaten | 760.125 | 1.020.108 | 1.118.202 | 1.381.377 | 1.531.061 |
| L01BC59 Trifluridine combinatiepreparaten | 4.110.459 | 3.857.231 | 3.551.706 | 2.790.285 | 3.570.046 |
| Totaal | 26.047.533 | 18.935.681 | 13.801.063 | 11.748.749 | 10.852.364 |